<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT932-8055</title>
	</head>
	<body>
		<main>
			<p>930520 FT  20 MAY 93 / UK Company News: Medeva in US dermatology alliance Medeva and Matrix of the US have formed a major alliance in the field of dermatology to commercialise the novel Therapeutic Implant products being developed by Matrix for the US and European markets. Medeva is to invest Dollars 10m (Pounds 6.4m) in new Matrix common stock at Dollars 15 per share and provide up to Dollars 12m development and milestone payments. Under the terms of the agreement, Medeva will purchase Matrix stock during the first year of collaboration.</p>
		</main>
</body></html>
            